Stock Analysis on Net

Procter & Gamble Co. (NYSE:PG)

$24.99

Common-Size Income Statement
Quarterly Data

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Procter & Gamble Co., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net sales
Cost of products sold
Gross profit
Selling, general and administrative expense
Indefinite-lived intangible asset impairment charge
Operating income
Interest expense
Interest income
Other non-operating income (expense), net
Earnings before income taxes
Income taxes
Net earnings
Net (earnings) loss attributable to noncontrolling interests
Net earnings attributable to Procter & Gamble (P&G)
Preferred dividends
Net earnings attributable to P&G available to common shareholders

Based on: 10-Q (reporting date: 2025-03-31), 10-Q (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-K (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-K (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-K (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-K (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-K (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30).


Cost of Products Sold
The cost of products sold as a percentage of net sales exhibits notable fluctuation over the periods. Initially, it hovered around the low 50% range but decreased to as low as approximately 47% during the 2020 period, indicating an improvement in cost efficiency. However, in recent quarters, costs rose again, reaching over 49%, suggesting some cost pressures or changes in product mix affecting margins.
Gross Profit
Gross profit margins align inversely with the cost of products sold and range typically between 44.65% and 53.14%. Peaks in gross profit occurred around 2020, coinciding with reduced cost of goods sold percentages. More recently, gross profit percentages have stabilized around the 50% mark, reflecting a recovery from the dip in mid-2022.
Selling, General and Administrative Expense (SG&A)
SG&A expenses show significant variability, generally ranging from about 23.42% to 30.68% of net sales. The lowest expenses occurred around mid-2022, improving operating leverage, whereas peaks such as the near 30% in late 2021 and early 2024 indicate periods of increased administrative or selling costs which may have dampened profitability.
Operating Income
Operating income percentage has experienced pronounced volatility, notably including a sharp negative dip to -30.37% in June 2019, likely impacted by a significant charge recorded that quarter. Aside from this anomaly, operating income mostly fluctuated between 15% and 27%, with stronger performance seen in late 2020 and late 2024. The general trend suggests resilience with recovery after periods of operational challenges.
Interest Expense and Interest Income
Interest expense remained relatively stable, generally ranging from -0.55% to -1.17% of net sales, with some increase in costs evident in recent periods. Interest income was consistently lower but showed a gradual increase over time, rising from around 0.05% in earlier periods to over 0.6% in recent quarters, offsetting some financing costs.
Other Non-Operating Income (Expense), Net
This item shows variability with occasional negative impacts, notably a substantial negative value near -2.55% in late 2024, and similar fluctuations throughout. Positive contributions from other non-operating sources, generally ranging below 1%, suggest some supplementary income streams, although their irregularity indicates limited predictability.
Earnings Before Income Taxes
Earnings before income taxes mirrored operating income trends, with a steep negative occurrence in mid-2019 and mostly positive values between 18% and 27% in other periods. This performance indicates consistent pre-tax profitability except during the exceptional impairment event.
Income Taxes
Income tax as a percentage of net sales varies between approximately -1% and -5.7%. The notable reduction in tax rate in mid-2019 correlates with the large loss event that quarter. Tax expense percentages rose again in some periods but generally show a conservative impact on net results.
Net Earnings
Net earnings closely reflect operating and pre-tax income patterns, ranging mostly between 15% and 22% of net sales, with a marked negative outlier at -30.64% in mid-2019. Aside from this, net earnings demonstrate a generally stable profitability trend with occasional quarterly variations.
Net Earnings Attributable to P&G
Earnings attributable to the company after dividends remained strong except for the noted negative mid-2019 period. The percentages range mostly between 15% and 21%, showing an overall healthy return to shareholders and resilience in the company’s core profitability despite some fluctuations in expenses and costs.
Summary of Trends
The data reveals a predominantly stable operating and profitability profile disrupted by one significant impairment event in mid-2019 evident in drastic drops in operating income and net earnings. Cost of goods sold percentages suggest a mild improvement around 2020 but have since experienced upward pressure. SG&A costs demonstrate some volatility impacting operating margins. Interest expenses have slightly increased recently relative to interest income, which has gradually improved. Other non-operating items are a minor and inconsistent contributor. Overall, financial performance exhibits recovery and resilience with earnings percentages consistently strong outside of the impairment-affected quarter.